Organ storage with University of Wisconsin solution is associated with improved outcomes after orthotopic heart transplantation

被引:42
作者
George, Timothy J. [1 ]
Arnaoutakis, George J. [1 ]
Baumgartner, William A. [1 ]
Shah, Ashish S. [1 ]
Conte, John V. [1 ]
机构
[1] Johns Hopkins Med Inst, Div Cardiac Surg, Baltimore, MD 21287 USA
关键词
heart transplantation; preservation solution; storage solution; UNOS; MYOCARDIAL PRESERVATION; CARDIAC TRANSPLANTATION; CELSIOR SOLUTION; ANTIOXIDANTS; GLUTATHIONE; MULTICENTER; STABILITY; PERFUSION;
D O I
10.1016/j.healun.2011.05.005
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BACKGROUND: Despite significant advances in cardiac allograft preservation, the optimal preservative solution is unknown. We evaluated the impact of the most commonly used solutions in the USA, the University of Wisconsin solution (UW) and Celsior solution (CS), on outcomes after orthotopic heart transplantation (OHT). METHODS: We retrospectively reviewed adult OHT recipients in the United Network for Organ Sharing (UNOS) database. Primary stratification was by preservation solution. The primary end-point was short-term survival (30 days and I year). Secondary end-points included common post-operative complications. Subgroup analysis was performed in high-risk allografts (donor age >50 years or ischemic time >4 hours). Risk-adjusted multivariate Cox proportional hazard regression was used to assess survival. RESULTS: From 2004 to 2009, 4,910 patients (3,107 UW and 1,803 CS) with sufficient preservation solution information for analysis underwent OHT. Baseline characteristics were well-matched between the two groups. UW was associated with a small but significantly improved survival compared with CS at 30 days (96.7% vs 95.4%, p = 0.02) and 1- year (89.6% vs 87.0%, p < 0.01). These survival differences persisted on multivariate analysis at 30 days (HR 1.47 [1.02 to 2.13], p < 0.05) and 1 year (HR 1.40 [1.14 to 1.73], p < 0.01). In the 1,455 patients with high-risk allografts, preservation with UW was associated with improved survival compared with CS at 30 days (94.3% vs 91.3%, p < 0.01) and at I year (84.2% vs 80.19%, p < 0.01), a difference that was significant according to multivariate Cox analysis at 30 days (HR 2.29 [1.39 to 3.76], p < 0.01) and 1 year (HR 1.61 [1.17 to 2.21], p < 0.01). CONCLUSIONS: Preservation with UW solution is associated with improved short-term survival compared with CS. Patients undergoing OHT with high-risk allografts have a similar survival benefit. Heart Lung Transplant 2011;30:1033-43 (C) 2011 International Society for Heart and Lung Transplantation. All rights reserved.
引用
收藏
页码:1033 / 1043
页数:11
相关论文
共 21 条
[11]   Celsior, a novel cardioplegic solution for arrest and storage in heart transplantation [J].
Llosa, JC ;
Lambert, JLR ;
Naya, JL ;
Gosalbez, F ;
Valle, JM .
TRANSPLANTATION PROCEEDINGS, 2000, 32 (08) :2589-2590
[12]   EXPERIMENTAL EVALUATION OF CELSIOR((R)), A NEW HEART PRESERVATION SOLUTION [J].
MENASCHE, P ;
TERMIGNON, JL ;
PRADIER, F ;
GROUSSET, C ;
MOUAS, C ;
ALBERICI, G ;
WEISS, M ;
PIWNICA, A ;
BLOCH, G .
EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 1994, 8 (04) :207-213
[13]   Influence of the Selected Antioxidants on the Stability of the Celsior Solution Used for Perfusion and Organ Preservation Purposes [J].
Ostrozka-Cieslik, Aneta ;
Dolinska, Barbara ;
Ryszka, Florian .
AAPS PHARMSCITECH, 2009, 10 (02) :468-475
[14]   Solutions for organ perfusion and storage: Haemorheologic aspects [J].
Panzera, P ;
Rotelli, MT ;
Salerno, AM ;
Cicco, G ;
Catalano, G ;
D'Elia, G ;
Greco, L ;
Lupo, L ;
Memeo, V .
TRANSPLANTATION PROCEEDINGS, 2005, 37 (06) :2456-2458
[15]   Elective cardiac surgery using Celsior or St. Thomas No. 2 solution:: a prospective, single-center, randomized pilot study [J].
Pereda, Daniel ;
Castella, Manuel ;
Pomar, Jose-Luis ;
Cartana, Ramon ;
Josa, Miguel ;
Barriuso, Clemente ;
Roman, Javier ;
Mulet, Jaime .
EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 2007, 32 (03) :501-506
[16]   Myocardial preservation using Celsior solution in cardiac transplantation: Early results and 5-year follow-up of a multicenter prospective study of 70 cardiac transplantations [J].
Remadi, JP ;
Baron, O ;
Roussel, JC ;
Al Habash, O ;
Treilhaud, M ;
Despins, P ;
Duveau, D ;
Michaud, JL .
ANNALS OF THORACIC SURGERY, 2002, 73 (05) :1495-1499
[17]   The Registry of the International Society for Heart and Lung Transplantation: Twenty-seventh official adult heart transplant report-2010 [J].
Stehlik, Josef ;
Edwards, Leah B. ;
Kucheryavaya, Anna Y. ;
Aurora, Paul ;
Christie, Jason D. ;
Kirk, Richard ;
Dobbels, Fabienne ;
Rahmel, Axel O. ;
Hertz, Marshall I. .
JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2010, 29 (10) :1089-1103
[18]   A multicenter, randomized, controlled trial of Celsior for flush and hypothermic storage of cardiac allografts [J].
Vega, JD ;
Ochsner, JL ;
Jeevanandam, V ;
McGiffin, DC ;
McCurry, KR ;
Mentzer, RM ;
Stringham, JC ;
Pierson, RN ;
Frazier, OH ;
Menkis, AH ;
Staples, ED ;
Modry, DL ;
Emery, RW ;
Piccione, W ;
Carrier, M ;
Hendry, PJ ;
Aziz, S ;
Furukawa, S ;
Pham, SM .
ANNALS OF THORACIC SURGERY, 2001, 71 (05) :1442-1447
[19]   Improved graft function using a new myocardial preservation solution: Celsior. Preliminary data from a randomized prospective study [J].
Wieselthaler, GM ;
Chevtchik, O ;
Konetschny, R ;
Moidl, R ;
Mallinger, R ;
Mares, P ;
Griessmacher, A ;
Grimm, M ;
Wolner, E ;
Laufer, G .
TRANSPLANTATION PROCEEDINGS, 1999, 31 (05) :2067-2068
[20]  
Wildhirt S M, 2000, Transpl Int, V13 Suppl 1, pS203, DOI 10.1111/j.1432-2277.2000.tb02021.x